Advent Life Sciences is a venture capital firm investing in life sciences businesses.
Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences, principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 15, 2022
Tridek-One
|
Series Unknown | €16M | Biotechnology | — |
Apr 25, 2022
Epitopea
|
Seed | £10.30M | Biotechnology | — |
Mar 22, 2021
Aura Biosciences
|
Series Unknown | $80M | Biotechnology | — |
Mar 17, 2021
Amphista Therapeutics
|
Series B | $53M | Biopharma | — |
Apr 7, 2020
Amphista Therapeutics
|
Series A | $7.50M | Biopharma | Yes |